GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (FRA:CEPS) » Definitions » FCF Yield %

CTI BioPharma (FRA:CEPS) FCF Yield % : -9.70 (As of May. 26, 2024)


View and export this data going back to 2007. Start your Free Trial

What is CTI BioPharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, CTI BioPharma's Trailing 12-Month Free Cash Flow is €-78.46 Mil, and Market Cap is €1,094.22 Mil. Therefore, CTI BioPharma's FCF Yield % for today is -9.70%.

The historical rank and industry rank for CTI BioPharma's FCF Yield % or its related term are showing as below:

FRA:CEPS' s FCF Yield % Range Over the Past 10 Years
Min: -9.7   Med: 0   Max: 0
Current: -9.7


FRA:CEPS's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -14.53 vs FRA:CEPS: -9.70

CTI BioPharma's FCF Margin % for the quarter that ended in Mar. 2023 was -128.96%.


CTI BioPharma FCF Yield % Historical Data

The historical data trend for CTI BioPharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTI BioPharma FCF Yield % Chart

CTI BioPharma Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -83.91 -29.99 -17.70 -35.06 -14.26

CTI BioPharma Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.05 -12.97 -8.34 -8.33 -22.54

Competitive Comparison of CTI BioPharma's FCF Yield %

For the Biotechnology subindustry, CTI BioPharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CTI BioPharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CTI BioPharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where CTI BioPharma's FCF Yield % falls into.



CTI BioPharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

CTI BioPharma's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-100.247 / 703.157366
=-14.26%

CTI BioPharma's annualized FCF Yield % for the quarter that ended in Mar. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-29.046 * 4 / 515.38704
=-22.54%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CTI BioPharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


CTI BioPharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of CTI BioPharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


CTI BioPharma (FRA:CEPS) Business Description

Traded in Other Exchanges
N/A
Address
3101 Western Avenue, Suite 800, Seattle, WA, USA, 98121
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

CTI BioPharma (FRA:CEPS) Headlines

No Headlines